Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature
Summary Autoimmune myelofibrosis (AIMF) is a distinct clinicopathological entity associated with diffuse bone marrow fibrosis and a benign clinical course. Distinction from neoplastic etiologies of marrow fibrosis, particularly primary myelofibrosis, is imperative, but few studies have documented hi...
Gespeichert in:
Veröffentlicht in: | Human pathology 2014-11, Vol.45 (11), p.2183-2191 |
---|---|
Hauptverfasser: | , , , , , , |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
container_end_page | 2191 |
---|---|
container_issue | 11 |
container_start_page | 2183 |
container_title | Human pathology |
container_volume | 45 |
creator | Vergara-Lluri, Maria E., MD Piatek, Caroline I., MD Pullarkat, Vinod, MD Siddiqi, Imran N., MD, PhD O'Connell, Casey, MD Feinstein, Donald I., MD Brynes, Russell K., MD |
description | Summary Autoimmune myelofibrosis (AIMF) is a distinct clinicopathological entity associated with diffuse bone marrow fibrosis and a benign clinical course. Distinction from neoplastic etiologies of marrow fibrosis, particularly primary myelofibrosis, is imperative, but few studies have documented histopathologic features in a large series. We describe 29 patients with AIMF, defined as marrow reticulin fibrosis and lymphocytic infiltration in the context of an established autoimmune disorder (secondary AIMF) or autoantibodies without a defined disorder (primary AIMF). Excluded were cases with atypical megakaryocytes, dysplasia, basophilia, osteosclerosis, unexplained splenomegaly, or neoplasms associated with myelofibrosis (MF). All cases were stained for reticulin, CD3, and CD20, with a subset additionally stained for CD138, κ , λ , immunoglobulin G (IgG), and IgG4. Lymphoid aggregates, where present, were classified into T-cell and B-cell patterns of distribution. Most patients (93%) presented with cytopenias. Sixty-nine percent (n = 20) were considered secondary AIMF and the remainder primary AIMF (n = 9). Peripheral blood showed absent-to-rare blasts and teardrop erythrocytes and absence of eosinophilia or basophilia. Characteristic bone marrow findings included hypercellularity with erythroid and megakaryocytic hyperplasias, mild reticulin fibrosis, intrasinusoidal hematopoiesis, T-cell pattern in lymphoid aggregates, mild polytypic plasmacytosis, and absence of IgG4-positive plasma cells. Primary and secondary AIMF were pathologically indistinguishable, except for an increased incidence of granulocytic hyperplasia in primary AIMF. This series confirms and expands the utility of the original diagnostic criteria for AIMF. Recognizing the characteristic morphology of AIMF and its associated clinical and laboratory features distinguishes autoimmune from neoplastic causes of MF and guides further evaluation and management. |
doi_str_mv | 10.1016/j.humpath.2014.07.017 |
format | Article |
fullrecord | <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_1654670894</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><els_id>1_s2_0_S0046817714003153</els_id><sourcerecordid>1654670894</sourcerecordid><originalsourceid>FETCH-LOGICAL-c594t-501aa3d4f7438490bbd235fc6d7292dccd07c6838566fa4680abc881873073943</originalsourceid><addsrcrecordid>eNqNkkuP1DAQhCMEYoeFnwCyxIVLQvsVOxxAqxUvaSUOwNny2B3GQxIPdgKaf4_DDCDtBU7uw9dlVVVX1WMKDQXaPt83u2U82HnXMKCiAdUAVXeqDZWc1Zp37G61ARBtralSF9WDnPcAlEoh71cXTDLNgKtN5a-WOYZxXCYk4xGH2IdtijnkF8ROZDl4OyOJExljOuziEL8ER3q085IwkzAR1hFnc5nt5EnC7wF_kNiTeYdkCDOmX-TD6l5vh4yPzu9l9fnN60_X7-qbD2_fX1_d1E52Yq4lUGu5F70SXIsOtlvPuOxd6xXrmHfOg3Kt5lq2bW9Fq8FundZUKw6Kd4JfVs9OuocUvy2YZzOG7HAY7IRxyYa2UrQK9H-hrOtUK_WKPr2F7uOSpmKkUFR0bI21UPJEuRJfTtibQwqjTUdDwayNmb05N2bWxgwoUxore0_O6st2RP9n63dFBXh1ArAkV_JNJruAk0MfErrZ-Bj--cXLWwpuCFNwdviKR8x_3ZjMDJiP69msV0MFAC_W-E9Zrr1n</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>1614920115</pqid></control><display><type>article</type><title>Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature</title><source>MEDLINE</source><source>Elsevier ScienceDirect Journals Complete</source><creator>Vergara-Lluri, Maria E., MD ; Piatek, Caroline I., MD ; Pullarkat, Vinod, MD ; Siddiqi, Imran N., MD, PhD ; O'Connell, Casey, MD ; Feinstein, Donald I., MD ; Brynes, Russell K., MD</creator><creatorcontrib>Vergara-Lluri, Maria E., MD ; Piatek, Caroline I., MD ; Pullarkat, Vinod, MD ; Siddiqi, Imran N., MD, PhD ; O'Connell, Casey, MD ; Feinstein, Donald I., MD ; Brynes, Russell K., MD</creatorcontrib><description>Summary Autoimmune myelofibrosis (AIMF) is a distinct clinicopathological entity associated with diffuse bone marrow fibrosis and a benign clinical course. Distinction from neoplastic etiologies of marrow fibrosis, particularly primary myelofibrosis, is imperative, but few studies have documented histopathologic features in a large series. We describe 29 patients with AIMF, defined as marrow reticulin fibrosis and lymphocytic infiltration in the context of an established autoimmune disorder (secondary AIMF) or autoantibodies without a defined disorder (primary AIMF). Excluded were cases with atypical megakaryocytes, dysplasia, basophilia, osteosclerosis, unexplained splenomegaly, or neoplasms associated with myelofibrosis (MF). All cases were stained for reticulin, CD3, and CD20, with a subset additionally stained for CD138, κ , λ , immunoglobulin G (IgG), and IgG4. Lymphoid aggregates, where present, were classified into T-cell and B-cell patterns of distribution. Most patients (93%) presented with cytopenias. Sixty-nine percent (n = 20) were considered secondary AIMF and the remainder primary AIMF (n = 9). Peripheral blood showed absent-to-rare blasts and teardrop erythrocytes and absence of eosinophilia or basophilia. Characteristic bone marrow findings included hypercellularity with erythroid and megakaryocytic hyperplasias, mild reticulin fibrosis, intrasinusoidal hematopoiesis, T-cell pattern in lymphoid aggregates, mild polytypic plasmacytosis, and absence of IgG4-positive plasma cells. Primary and secondary AIMF were pathologically indistinguishable, except for an increased incidence of granulocytic hyperplasia in primary AIMF. This series confirms and expands the utility of the original diagnostic criteria for AIMF. Recognizing the characteristic morphology of AIMF and its associated clinical and laboratory features distinguishes autoimmune from neoplastic causes of MF and guides further evaluation and management.</description><identifier>ISSN: 0046-8177</identifier><identifier>EISSN: 1532-8392</identifier><identifier>DOI: 10.1016/j.humpath.2014.07.017</identifier><identifier>PMID: 25282037</identifier><language>eng</language><publisher>United States: Elsevier Inc</publisher><subject>Adult ; Aged ; Autoimmune diseases ; Autoimmune Diseases - pathology ; Autoimmune disorders ; Autoimmune myelofibrosis ; Bone marrow ; Bone marrow fibrosis ; Disease ; Female ; Hepatitis ; Humans ; IgG4 related disease ; Immune system ; Lupus ; Lymphocytes ; Male ; Medical prognosis ; Metabolic disorders ; Middle Aged ; Morphologic criteria ; Non-neoplastic fibrosis ; Pathology ; Primary Myelofibrosis - pathology ; Transplants & implants ; Tumors ; Young Adult</subject><ispartof>Human pathology, 2014-11, Vol.45 (11), p.2183-2191</ispartof><rights>Elsevier Inc.</rights><rights>2014 Elsevier Inc.</rights><rights>Copyright © 2014 Elsevier Inc. All rights reserved.</rights><rights>Copyright Elsevier Limited Nov 2014</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c594t-501aa3d4f7438490bbd235fc6d7292dccd07c6838566fa4680abc881873073943</citedby><cites>FETCH-LOGICAL-c594t-501aa3d4f7438490bbd235fc6d7292dccd07c6838566fa4680abc881873073943</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://dx.doi.org/10.1016/j.humpath.2014.07.017$$EHTML$$P50$$Gelsevier$$H</linktohtml><link.rule.ids>314,780,784,3550,27924,27925,45995</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/25282037$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Vergara-Lluri, Maria E., MD</creatorcontrib><creatorcontrib>Piatek, Caroline I., MD</creatorcontrib><creatorcontrib>Pullarkat, Vinod, MD</creatorcontrib><creatorcontrib>Siddiqi, Imran N., MD, PhD</creatorcontrib><creatorcontrib>O'Connell, Casey, MD</creatorcontrib><creatorcontrib>Feinstein, Donald I., MD</creatorcontrib><creatorcontrib>Brynes, Russell K., MD</creatorcontrib><title>Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature</title><title>Human pathology</title><addtitle>Hum Pathol</addtitle><description>Summary Autoimmune myelofibrosis (AIMF) is a distinct clinicopathological entity associated with diffuse bone marrow fibrosis and a benign clinical course. Distinction from neoplastic etiologies of marrow fibrosis, particularly primary myelofibrosis, is imperative, but few studies have documented histopathologic features in a large series. We describe 29 patients with AIMF, defined as marrow reticulin fibrosis and lymphocytic infiltration in the context of an established autoimmune disorder (secondary AIMF) or autoantibodies without a defined disorder (primary AIMF). Excluded were cases with atypical megakaryocytes, dysplasia, basophilia, osteosclerosis, unexplained splenomegaly, or neoplasms associated with myelofibrosis (MF). All cases were stained for reticulin, CD3, and CD20, with a subset additionally stained for CD138, κ , λ , immunoglobulin G (IgG), and IgG4. Lymphoid aggregates, where present, were classified into T-cell and B-cell patterns of distribution. Most patients (93%) presented with cytopenias. Sixty-nine percent (n = 20) were considered secondary AIMF and the remainder primary AIMF (n = 9). Peripheral blood showed absent-to-rare blasts and teardrop erythrocytes and absence of eosinophilia or basophilia. Characteristic bone marrow findings included hypercellularity with erythroid and megakaryocytic hyperplasias, mild reticulin fibrosis, intrasinusoidal hematopoiesis, T-cell pattern in lymphoid aggregates, mild polytypic plasmacytosis, and absence of IgG4-positive plasma cells. Primary and secondary AIMF were pathologically indistinguishable, except for an increased incidence of granulocytic hyperplasia in primary AIMF. This series confirms and expands the utility of the original diagnostic criteria for AIMF. Recognizing the characteristic morphology of AIMF and its associated clinical and laboratory features distinguishes autoimmune from neoplastic causes of MF and guides further evaluation and management.</description><subject>Adult</subject><subject>Aged</subject><subject>Autoimmune diseases</subject><subject>Autoimmune Diseases - pathology</subject><subject>Autoimmune disorders</subject><subject>Autoimmune myelofibrosis</subject><subject>Bone marrow</subject><subject>Bone marrow fibrosis</subject><subject>Disease</subject><subject>Female</subject><subject>Hepatitis</subject><subject>Humans</subject><subject>IgG4 related disease</subject><subject>Immune system</subject><subject>Lupus</subject><subject>Lymphocytes</subject><subject>Male</subject><subject>Medical prognosis</subject><subject>Metabolic disorders</subject><subject>Middle Aged</subject><subject>Morphologic criteria</subject><subject>Non-neoplastic fibrosis</subject><subject>Pathology</subject><subject>Primary Myelofibrosis - pathology</subject><subject>Transplants & implants</subject><subject>Tumors</subject><subject>Young Adult</subject><issn>0046-8177</issn><issn>1532-8392</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2014</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqNkkuP1DAQhCMEYoeFnwCyxIVLQvsVOxxAqxUvaSUOwNny2B3GQxIPdgKaf4_DDCDtBU7uw9dlVVVX1WMKDQXaPt83u2U82HnXMKCiAdUAVXeqDZWc1Zp37G61ARBtralSF9WDnPcAlEoh71cXTDLNgKtN5a-WOYZxXCYk4xGH2IdtijnkF8ROZDl4OyOJExljOuziEL8ER3q085IwkzAR1hFnc5nt5EnC7wF_kNiTeYdkCDOmX-TD6l5vh4yPzu9l9fnN60_X7-qbD2_fX1_d1E52Yq4lUGu5F70SXIsOtlvPuOxd6xXrmHfOg3Kt5lq2bW9Fq8FundZUKw6Kd4JfVs9OuocUvy2YZzOG7HAY7IRxyYa2UrQK9H-hrOtUK_WKPr2F7uOSpmKkUFR0bI21UPJEuRJfTtibQwqjTUdDwayNmb05N2bWxgwoUxore0_O6st2RP9n63dFBXh1ArAkV_JNJruAk0MfErrZ-Bj--cXLWwpuCFNwdviKR8x_3ZjMDJiP69msV0MFAC_W-E9Zrr1n</recordid><startdate>20141101</startdate><enddate>20141101</enddate><creator>Vergara-Lluri, Maria E., MD</creator><creator>Piatek, Caroline I., MD</creator><creator>Pullarkat, Vinod, MD</creator><creator>Siddiqi, Imran N., MD, PhD</creator><creator>O'Connell, Casey, MD</creator><creator>Feinstein, Donald I., MD</creator><creator>Brynes, Russell K., MD</creator><general>Elsevier Inc</general><general>Elsevier Limited</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>K9.</scope><scope>7X8</scope><scope>7T5</scope><scope>H94</scope></search><sort><creationdate>20141101</creationdate><title>Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature</title><author>Vergara-Lluri, Maria E., MD ; Piatek, Caroline I., MD ; Pullarkat, Vinod, MD ; Siddiqi, Imran N., MD, PhD ; O'Connell, Casey, MD ; Feinstein, Donald I., MD ; Brynes, Russell K., MD</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c594t-501aa3d4f7438490bbd235fc6d7292dccd07c6838566fa4680abc881873073943</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2014</creationdate><topic>Adult</topic><topic>Aged</topic><topic>Autoimmune diseases</topic><topic>Autoimmune Diseases - pathology</topic><topic>Autoimmune disorders</topic><topic>Autoimmune myelofibrosis</topic><topic>Bone marrow</topic><topic>Bone marrow fibrosis</topic><topic>Disease</topic><topic>Female</topic><topic>Hepatitis</topic><topic>Humans</topic><topic>IgG4 related disease</topic><topic>Immune system</topic><topic>Lupus</topic><topic>Lymphocytes</topic><topic>Male</topic><topic>Medical prognosis</topic><topic>Metabolic disorders</topic><topic>Middle Aged</topic><topic>Morphologic criteria</topic><topic>Non-neoplastic fibrosis</topic><topic>Pathology</topic><topic>Primary Myelofibrosis - pathology</topic><topic>Transplants & implants</topic><topic>Tumors</topic><topic>Young Adult</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Vergara-Lluri, Maria E., MD</creatorcontrib><creatorcontrib>Piatek, Caroline I., MD</creatorcontrib><creatorcontrib>Pullarkat, Vinod, MD</creatorcontrib><creatorcontrib>Siddiqi, Imran N., MD, PhD</creatorcontrib><creatorcontrib>O'Connell, Casey, MD</creatorcontrib><creatorcontrib>Feinstein, Donald I., MD</creatorcontrib><creatorcontrib>Brynes, Russell K., MD</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>ProQuest Health & Medical Complete (Alumni)</collection><collection>MEDLINE - Academic</collection><collection>Immunology Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><jtitle>Human pathology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Vergara-Lluri, Maria E., MD</au><au>Piatek, Caroline I., MD</au><au>Pullarkat, Vinod, MD</au><au>Siddiqi, Imran N., MD, PhD</au><au>O'Connell, Casey, MD</au><au>Feinstein, Donald I., MD</au><au>Brynes, Russell K., MD</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature</atitle><jtitle>Human pathology</jtitle><addtitle>Hum Pathol</addtitle><date>2014-11-01</date><risdate>2014</risdate><volume>45</volume><issue>11</issue><spage>2183</spage><epage>2191</epage><pages>2183-2191</pages><issn>0046-8177</issn><eissn>1532-8392</eissn><abstract>Summary Autoimmune myelofibrosis (AIMF) is a distinct clinicopathological entity associated with diffuse bone marrow fibrosis and a benign clinical course. Distinction from neoplastic etiologies of marrow fibrosis, particularly primary myelofibrosis, is imperative, but few studies have documented histopathologic features in a large series. We describe 29 patients with AIMF, defined as marrow reticulin fibrosis and lymphocytic infiltration in the context of an established autoimmune disorder (secondary AIMF) or autoantibodies without a defined disorder (primary AIMF). Excluded were cases with atypical megakaryocytes, dysplasia, basophilia, osteosclerosis, unexplained splenomegaly, or neoplasms associated with myelofibrosis (MF). All cases were stained for reticulin, CD3, and CD20, with a subset additionally stained for CD138, κ , λ , immunoglobulin G (IgG), and IgG4. Lymphoid aggregates, where present, were classified into T-cell and B-cell patterns of distribution. Most patients (93%) presented with cytopenias. Sixty-nine percent (n = 20) were considered secondary AIMF and the remainder primary AIMF (n = 9). Peripheral blood showed absent-to-rare blasts and teardrop erythrocytes and absence of eosinophilia or basophilia. Characteristic bone marrow findings included hypercellularity with erythroid and megakaryocytic hyperplasias, mild reticulin fibrosis, intrasinusoidal hematopoiesis, T-cell pattern in lymphoid aggregates, mild polytypic plasmacytosis, and absence of IgG4-positive plasma cells. Primary and secondary AIMF were pathologically indistinguishable, except for an increased incidence of granulocytic hyperplasia in primary AIMF. This series confirms and expands the utility of the original diagnostic criteria for AIMF. Recognizing the characteristic morphology of AIMF and its associated clinical and laboratory features distinguishes autoimmune from neoplastic causes of MF and guides further evaluation and management.</abstract><cop>United States</cop><pub>Elsevier Inc</pub><pmid>25282037</pmid><doi>10.1016/j.humpath.2014.07.017</doi><tpages>9</tpages><oa>free_for_read</oa></addata></record> |
fulltext | fulltext |
identifier | ISSN: 0046-8177 |
ispartof | Human pathology, 2014-11, Vol.45 (11), p.2183-2191 |
issn | 0046-8177 1532-8392 |
language | eng |
recordid | cdi_proquest_miscellaneous_1654670894 |
source | MEDLINE; Elsevier ScienceDirect Journals Complete |
subjects | Adult Aged Autoimmune diseases Autoimmune Diseases - pathology Autoimmune disorders Autoimmune myelofibrosis Bone marrow Bone marrow fibrosis Disease Female Hepatitis Humans IgG4 related disease Immune system Lupus Lymphocytes Male Medical prognosis Metabolic disorders Middle Aged Morphologic criteria Non-neoplastic fibrosis Pathology Primary Myelofibrosis - pathology Transplants & implants Tumors Young Adult |
title | Autoimmune myelofibrosis: an update on morphologic features in 29 cases and review of the literature |
url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A10%3A00IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Autoimmune%20myelofibrosis:%20an%20update%20on%20morphologic%20features%20in%2029%20cases%20and%20review%20of%20the%20literature&rft.jtitle=Human%20pathology&rft.au=Vergara-Lluri,%20Maria%20E.,%20MD&rft.date=2014-11-01&rft.volume=45&rft.issue=11&rft.spage=2183&rft.epage=2191&rft.pages=2183-2191&rft.issn=0046-8177&rft.eissn=1532-8392&rft_id=info:doi/10.1016/j.humpath.2014.07.017&rft_dat=%3Cproquest_cross%3E1654670894%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=1614920115&rft_id=info:pmid/25282037&rft_els_id=1_s2_0_S0046817714003153&rfr_iscdi=true |